Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Acute Demyelinating Optic Neuritis
NCT01757691Phase 2Terminated
- Sponsor
- Novartis
- Start
- Aug 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fingolimod in acute demyelinating optic neuritis (ON), sponsored by Novartis. Started Aug 2013; status: terminated.
02
Drugs
fingolimod
03
Conditions
acute demyelinating optic neuritis (ON)
Beyond the preview
Go deeper on NCT01757691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757691.